Pacific Bio (PACB) Tops Q3 EPS by 2c

Pacific Bio (NASDAQ: PACB) reported Q3 EPS of ($0.27), $0.02 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $55.69 million versus the consensus estimate of $48.72 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity